Company
Last deal
$50.M
Amount
Post-IPO Debt
Stage
30.04.2024
Date
6
all rounds
$125.6M
Total amount
General
About Company
TriSalus Life Sciences develops infusion systems for interventional radiology.
Industry
Sector :
Subsector :
founded date
01.01.2009
Number of employees
Company Type
For Profit
Last funding type
Post-IPO Debt
IPO status
Private